Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Cernevit, Powder for Solution for Injection or Infusion - PA2299/019/001
- Dalacin T Topical Lotion 10 mg/ml Cutaneous Emulsion - PA0822/121/001
- Dalmane 15mg Hard Capsules - PA2010/039/001
- Mivacron 2mg/ml Solution for Injection - PA1691/031/001
- Molipaxin 100mg Hard Capsules - PA540/056/002
- MST Continus 5mg Prolonged Release Tablets - PA1688/004/001
- Piriton 4mg Tablets - PA0678/080/001
- Risonate Once Weekly 35mg Film Coated Tablets - PA0749/064/001
- Sotoger 80mg Tablets - PA0577/021/001
- Tritace 1.25mg Tablets - PA0540/084/005
- Truxima Concentrate for Solution for Infusion - EU/1/16/1167/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Anapen Junior 150mcg in 0.3ml Solution for Injection in a Pre Filled Syringe - PA22580/001/001
- MST Continus 10mg Prolonged Release Tablets - PA1688/004/002
- Ogivri 150mg Powder for Concentrate for Solution for Infusion - EU/1/18/1341/001
- Oxycontin 20mg Prolonged Release Tablets - PA1688/005/003
- Roactemra 162mg Solution for Injection in Pre Filled Pen - EU/1/08/492/009
- Uniphyllin Continus 300mg Prolonged Released Tablets - PA1688/011/002
- Uniphyllin Continus 400mg Prolonged Release Tablets - PA1688/011/003
Please see the shortages section of the HPRA website for further information.
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.